PBS Calendars

Page last updated: 24 March 2026

PBS related activities surrounding the PBAC meeting cycles

Sponsors who are concerned they cannot meet the deadline to list a new brand that will trigger a first new brand price reduction, are encouraged to email PBSPricing@health.gov.au to discuss available options.

If you are considering applying to have a drug listed on the PBS, it is recommended that you contact the Office of Health Technology Assessment (OHTA) to discuss the listing steps. If you are unsure of the most appropriate person to contact, the Industry Liaison Officer will be able to assist.

All contact details are available from the PBS contacts page.

PBAC Cycle Timeframe for 2025 - 2027

PBAC Cycle Timeframe for 2025 - 2027 (PDF 436KB) - (Word 64KB)

MEETING

2025/3
5-7 November

2026/1
11-13 March

2026/2

8-10 July

2026/3

4-6 November

2027/1

10-12 March

Activity

Wk

Date

Wk

Date

Wk

Date

Wk

Date

Wk

Date

Deadline for Notice of Intent for integrated co-dependent submissions (Wednesday 5pm AEST)

-8

14 May 2025

-8

10 Sep 2025

-8

14 Jan 2026

-8

13 May 2026

-8

9 Sep 2026

Requested date for Notice of Intent for Category 1-4 and Committee Secretariat submissions and Standard Re-entry resubmissions (Wednesday 5pm AEST)

 

*NOIs will continue to be accepted up to 20 business days before the submission due day

-8

 

-8

17 Sept 2025

-8

14 Jan 2026

-8

13 May 2026

-8

9 Sep 2026

 

-7

 

-7

 

-7

 

-7

 

-7

 

 

-6

 

-6

 

-6

 

-6

 

-6

 

 

-5

 

-5

 

-5

 

-5

 

-5

 

Deadline for Notice of Intent for Category 1-4 and Committee Secretariat submissions and Standard Re-entry resubmissions (Wednesday 5pm AEST)

-4

11 June 2025

-4

 

-4

 

-4

 

-4

 

Deadline for integrated co-dependent submissions (Wednesday 5pm AEST)

-4

11 June 2025

-4

8 Oct 2025

-4

11 Feb 2026

-4

10 June 2026

-4

7 Oct 2026

 

-3

 

-3

 

-3

 

-3

 

-3

 

 

-2

 

-2

 

-2

 

-2

 

-2

 

 

-1

 

-1

 

-1

 

-1

 

-1

 

Deadline for Category 1 to 4 and Committee Secretariat submissions; and Facilitated Resolution Pathway and Standard Re-entry Pathway resubmissions (Wednesday 5pm AEST)

0

9 July 2025

0

5 Nov 2025

0

11 Mar 2026

0

8 Jul 2026

0

4 Nov 2026

 

1

 

1

 

1

 

1

 

1

 

Publication of the main Agenda on web (Wednesday)

2

N/A

2

19 Nov 2025

2

25 Mar 2026

2

22 Jul 2026

2

18 Nov 2026

Consumer Consultation opens

(Wednesday)

2

N/A

2

19 Nov 2025

2

25 Mar 2026

2

22 Jul 2026

2

18 Nov 2026

Publication of the main Agenda on web (Wednesday)

3

30 Jul 2025

3

N/A

3

N/A

3

N/A

3

N/A

Consumer Consultation opens

(Wednesday)

3

30 Jul 2025

3

N/A

3

N/A

3

N/A

3

N/A

 

4

 

4

 

4

 

4

 

4

 

Deadline for pre-submission meeting requests to meet 8 week cut-off

5

15 Aug 2025

5

12 Dec 2025

5

17 Apr 2026

5

14 Aug 2026

5

11 Dec 2026

Deadline for Notice of Intent for Re-entry Pathway resubmissions (Friday 5pm AEST)

6

22 Aug 2025

6

19 Dec 2025

6

24 Apr 2026

6

21 Aug 2026

6

18 Dec 2026

Deadline for Early Re-entry Pathway resubmissions (Friday 5pm AEST)

7

29 Aug 2025

7

2 Jan 2026

(Dept Shutdown 25 De – 1 Jan)

7

1 May 2026

7

28 Aug 2026

7

24 Dec 2026

(Dept Shutdown 25 Dec – 3 Jan)

Publication of the updated Agenda on web

(Friday)

8

5 Sept 2025

8

9 Jan 2026

8

8 May 2026

8

4 Sep 2026

8

8 Jan 2027

Pre-submission meetings: 8 week cut-off

9

8-12 Sept 2025

9

12-16 Jan 2026

9

11-15 May 2026

9

7-11 Sep 2026

9

11-15 Jan 2027

Consumer Consultation closes (Wednesday);

10

N/A

10

14 Jan 2026

10

20 May 2026

10

16 Sept 2026

10

20 Jan 2027

Submission commentaries to Applicants (Wednesday)

10

17 Sept 2025

10

21 Jan 2026

10

20 May 2026

10

16 Sep 2026

10

20 Jan 2027

Consumer Consultation closes (Wednesday); and

11

24 Sep 2025

11

N/A

11

N/A

11

N/A

11

N/A

Applicants’ Pre-Subcommittee Responses (PSCRs) to PBAC Secretariat (midday Wednesday)

11

24 Sep 2025

11

28 Jan 2026

11

27 May 2026

11

23 Sep 2026

11

27 Jan 2027

DUSC and ESC meetings include joint meeting (Wednesday-Friday)

12

N/A

12

4-6 Feb 2026

12

3-5 Jun 2026

12

30 Sep – 2 Oct

12

3-5 Feb 2027

DUSC meeting (Thursday-Friday)

12

2-3 Oct 2025

12

5-6 Feb 2026

12

N/A

12

N/A

12

N/A

 

ESC meeting (Monday-Tuesday)

13

7-8 Oct 2025
(6 PH)

13

4-5 Feb 2026

13

N/A

13

N/A

13

N/A

Deadline for item delist submissions (Monday 5pm AEST)

14

13 Oct 2025

14

16 Feb 2026

14

16 Jun 2026

14

12 Oct 2026

14

15 Feb 2027

Submission overviews, ESC, DUSC & ATAGI (vaccine submissions) advice & summary of consumer inputs to Applicants (Wednesday)

15

22 Oct 2025

15

25 Feb 2026

15

24 Jun 2026

15

21 Oct 2026

15

25 Feb 2027

Applicants send Pre-PBAC Responses to PBAC Secretariat (by midday Wednesday)

16

29 Oct 2025

16

4 Mar 2026

16

1 Jul 2026

16

28 Oct 2026

16

3 Mar 2027

PBAC MEETING (Wednesday-Friday)

17

5-7 Nov 2025

17

11-13 March 2026

17

8-10 July 2026

17

4-6 Nov 2026

17

10-12 March 2027

POST PBAC PROCEDURES:

18

 

18

 

18

 

18

 

18

 

 

19

 

19

 

19

 

19

 

19

 

Ratified Minutes (positive outcomes) to Applicants (Friday)

20

28 Nov 2025

20

2 Apr 2026

(3 Apr PH)

20

31 Jul 2026

20

27 Nov 2026

20

1 Apr 2027

Publication of the PBAC December Intracycle Agenda on web (Friday)

21

5 Dec 2025

21

N/A

21

N/A

21

4 Dec 2026

21

N/A

PBAC DECEMBER INTRACYCLE MEETING (Wednesday)

22

10 Dec 2025

22

N/A

22

N/A

22

9 Dec 2026

22

N/A

Ratified Minutes (all other outcomes) to Applicants (Friday)

22

12 Dec 2025

22

17 Apr 2026

22

14 Aug 2026

22

11 Dec 2026

22

16 Apr 2027

Post-PBAC meetings with PBAC Chair (Tue-Wed)

23

16-17 Dec 2025

23

21-22 Apr 2026

23

18-19 Aug 2026

23

15-16 Dec 2026

23

20-21 Apr 2027

Posting of outcomes on website following Applicants’ comments (Friday); and deadline for Notice of Intent for Early Resolution Pathway resubmissions (Friday 5pm AEST)

23

19 Dec 2025

23

24 Apr 2026

23

21 Aug 2025

23

18 Dec 2026 (24 Dec – 3 Jan Dept shutdown)

23

23 Apr 2027

Deadline for Independent Review requests for reconsideration at the meeting following the next meeting (Friday); and

deadline for Early Resolution Pathway resubmissions (Friday 5pm AEST)

24

2 Jan 2026

(25 Dec – 1 Jan Dept shutdown)

24

1 May 2026

24

28 Aug 2026

24

24 Dec 2026

(24 Dec – 3 Jan Dept shutdown)

24

30 Apr 2027

Publication of the PBAC Intracycle Agenda on web (Friday) (except December meeting)

24

N/A

24

1 May 2026

24

28 Aug 2026

24

N/A

24

30 Apr 2027

PBAC INTRACYCLE MEETING (Friday) (except December meeting); and

25

N/A

25

8 May 2026

25

4 Sep 2026

25

N/A

25

7 May 2027

PBAC December Intracycle ratified minutes (positive outcomes) to Applicants (Friday)

25

9 Jan 2026

25

N/A

25

N/A

25

8 Jan 2027

25

N/A

 

26

 

26

 

26

 

26

 

26

 

Draft Public Summary Documents (PSDs) to Applicants (Friday)

27

 

27

22 May 2026

27

18 Sep 2026

27

 

27

21 May 2027

PBAC December Intracycle ratified minutes (all other outcomes) to Applicants (Friday)

27

23 Jan 2026

27

 

27

 

27

22 Jan 2027

27

N/A

PBAC December Intracycle Post-PBAC meetings with PBAC Chair (Tue-Wed)

28

27-28 Jan 2026

28

N/A

28

N/A

28

27-28 Jan 2027

(Australia Day 26 Jan)

28

N/A

PBAC Intracycle ratified minutes (positive outcomes) to Applicants (Friday) (except December meeting)

28

N/A

28

29 May 2026

28

25 Sep 2026

28

N/A

28

28 May 2027

PBAC December Intracycle posting of outcomes on website (Friday)

28

30 Jan 2026

28

N/A

28

N/A

28

29 Jan 2027

28

N/A

 

29

 

29

 

29

 

29

 

29

 

PBAC Intracycle ratified minutes (all other outcomes) to Applicants (Friday) (except December meeting)

30

13 Feb 2026

30

12 June 2026

30

9 Oct 2026

30

12 Feb 2027

30

11 June 2027

PBAC Intracycle Post-PBAC meetings with PBAC Chair (Tue-Wed) (except December meeting)

31

N/A

31

16-17 June 2026

31

13-14 Oct 2026

31

N/A

31

15-16 June 2027

Final PSDs to Applicants (Friday); and

 

31

20 Feb 2026

31

19 June 2026

31

16 Oct 2026

31

19 Feb 2027

31

18 June 2027

PBAC Intracycle posting of outcomes on website (except December meeting)

31

N/A

31

19 June 2026

31

16 Oct 2026

31

N/A

31

18 June 2027

Draft PBAC December Intracycle PSDs to Applicants (Friday)

32

27 Feb 2026

32

N/A

32

N/A

32

26 Feb 2027

32

N/A

 

33

 

33

 

33

 

33

 

33

 

 

34

 

34

 

34

 

34

 

34

 

PSDs published on website (Friday)

35

20 Mar 2026

35

17 July 2026

35

13 Nov 2026

35

19 Mar 2027

35

16 July 2027

Draft PBAC Intracycle PSDs to Applicants (Friday) (except December meeting)

35

N/A

35

17 July 2026

35

13 Nov 2026

35

N/A

35

16 July 2027

Final PBAC December Intracycle PSDs to Applicants (Friday)

36

27 March 2026

36

N/A

36

N/A

36

25 Mar 2027

(26 Mar Good Friday)

36

N/A

 

37

 

37

 

37

 

37

 

37

 

 

38

 

38

 

38

 

38

 

38

 

Final PBAC Intracycle PSDs to Applicants (Friday) (except December meeting)

39

N/A

39

14 Aug 2026

39

11 Dec 2026

39

N/A

39

13 Aug 2027

PBAC December Intracycle PSDs published on website (Friday)

40

24 Apr 2026

40

N/A

40

N/A

40

23 Apr 2027

40

N/A

 

41

 

41

 

41

 

41

 

41

 

 

42

 

42

 

42

 

42

 

42

 

PBAC Intracycle PSDs published on website (Friday) (except December meeting)

43

N/A

43

11 Sept 2026

43

15 Jan 2027

43

N/A

43

10 Sep 2027

PBAC = Pharmaceutical Benefits Advisory Committee

“responsible persons” = legal wording requirement for terminology – previously known as sponsors
DUSC = Drug Utilisation Sub Committee    
ESC = Economic Sub Committee
ATAGI = Australian Technical Advisory Group on Immunisation
PSDs = Public Summary Documents
TBC = To be Confirmed
    
*  These dates may vary based on the number of submissions received    

Accessibility

The documents on this page may not be accessible. If you need help please contact the HTA Support Unit (htasupportunit@health.gov.au)

Pre-submission meetings

Sponsors may apply for a pre-submission meeting with the Department at any time. Pre-submission meetings are held throughout the entire PBAC meeting cycle, subject to availability. Please refer to the PBS Calendar above in relation to cut-off dates for applications submitting to the next major submission deadline. Additional information on procedures and links to application and briefing paper templates are outlined in the Procedure guidance for listing medicines on the Pharmaceutical Benefits Scheme.

If the item to be discussed is a co-dependent technology, sponsors should separately contact the Health Technology Assessment (HTA) team (hta@health.gov.au) to discuss the required MSAC processes.

Health technologies are co-dependent if their use needs to be combined (either sequentially or simultaneously) to achieve or enhance the intended clinical effect of either technology.  For example, a drug/test combination where a new medicine seeking listing on the PBS may have a related pathology test that helps to determine the population group for that medicine.

If you have any questions regarding pre-submission meetings, please contact the Pre-submission Meetings Team via email (PBACpresubmissionmeetings@health.gov.au).